Researchers from the Universities of Melbourne, York, Warwick and Oxford have shed light on how encapsulated viruses like hepatitis B, dengue and SARS-CoV-2 hijack the protein manufacturing and distribution pathways in the cell—they have also identified a potential broad spectrum anti-viral drug target to stop them in their tracks.
Click here for original story, Sugar-coated viral proteins hijack and hitch a ride out of cells
Source: Phys.org